<DOC>
	<DOCNO>NCT01570855</DOCNO>
	<brief_summary>The purpose study screen chemotherapy drug currently use treat lung cancer determine effective treatment base result chemo sensitivity test patient cancer cell laboratory . The result screen influence patient treatment .</brief_summary>
	<brief_title>Chemotherapy Resistance Sensitivity Testing Lung Tumors</brief_title>
	<detailed_description>The chemosensitivity assay perform tissue obtain diagnostic fine needle aspiration , core biopsy , excisional biopsy lung lesion . Cancer cell ( Bulk tumor ) Cancer Stem Cells ( CSCs ) isolate expanded laboratory . The drug screen assay use evaluate response CSCs cancer cell various chemotherapy regimen .</detailed_description>
	<criteria>suspect confirmed diagnosis lung cancer undergo fine needle aspiration , core biopsy , excisional biopsy diagnosis . Chemotherapy must clinically indicate treatment patient 's qualifying disease Patient must least 18 year age Patient must sign IRB approve informed consent form data collection study prior entry data enrollment form database . Patient pathology show benign pathology sample submit Patient indicate receive chemotherapy disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Lung cancer</keyword>
	<keyword>chemosensitivity</keyword>
</DOC>